Renovion.

Renovion, a preclinical stage pharmaceutical startup, raised nearly $5 million in equity from eight investors. The company hopes to raise a total of $7 million and plans to use some of the proceeds to pay the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT